FLEMINGTON, NJ - New sessions of LIVESTRONG at the YMCA, a program to help adult cancer survivors rebuild strength and stamina, will begin in September at the Hunterdon County YMCA. The 12-week program is free and open to all; Y membership is not required. Family members of cancer survivors are also invited to participate at no cost.
LIVESTRONG at the YMCA is a physical activity and well-being program designed to help adult cancer survivors achieve their holistic health goals. This research-based program offers people affected by cancer a safe, supportive environment to participate in physical and social activities. The focus is on strengthening the whole person in a small group personal training environment.
Beginning Friday, Sept. 6, a daytime session will meet Mondays, Tuesdays, and Fridays from 1:30 to 3 p.m. An evening option will also be available. Both sessions will be held at the Deer Path Branch, 144 West Woodschurch Rd., Flemington.
“Participants work with specially trained Y staff, to achieve their personal goals,” said Program Coordinator Beth Carpenter. “Goals such as building muscle mass and strength; increasing flexibility and endurance; and improving confidence and self-esteem are the focus of the program.”
In addition to the physical benefits of the program, the Y provides a supportive environment where people can connect during treatment and beyond. By focusing on the whole person and not the disease, LIVESTRONG at the YMCA helps people move beyond cancer in spirit, mind and body.
A graduate of the program says this about her experience, “It gave me not only the opportunity to make me feel that I accomplished something physically but also to accomplish something emotionally. Just being surrounded by others who know how you feel is rewarding, not to mention that everybody is cheering you on to get to your goals as we work as a group.”
Cancer survivors who participated in the LIVESTRONG at the YMCA program exhibited improvements in physical activity, fitness and quality of life, according to research conducted by Drs. Melinda Irwin of Yale Cancer Center and Jennifer Ligibel, senior physician in the Susan F. Smith Center for Women’s Cancers, Dana Farber Cancer Institute. The findings were presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.